BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 34445641)

  • 1. Interactions of Bacteriophages with Animal and Human Organisms-Safety Issues in the Light of Phage Therapy.
    Podlacha M; Grabowski Ł; Kosznik-Kawśnicka K; Zdrojewska K; Stasiłojć M; Węgrzyn G; Węgrzyn A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage-Based Biotechnological Applications.
    Santos SB; Azeredo J
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31405109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
    Maciejewska B; Olszak T; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dawn of phage therapy.
    Rehman S; Ali Z; Khan M; Bostan N; Naseem S
    Rev Med Virol; 2019 Jul; 29(4):e2041. PubMed ID: 31050070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotechnological applications of bacteriophages: State of the art.
    Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM
    Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.
    Dąbrowska K
    Med Res Rev; 2019 Sep; 39(5):2000-2025. PubMed ID: 30887551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
    Zurabov F; Zhilenkov E
    Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: bacteriophages in gastroenterology-from biology to clinical applications.
    Sabino J; Hirten RP; Colombel JF
    Aliment Pharmacol Ther; 2020 Jan; 51(1):53-63. PubMed ID: 31696976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage interactions with mammalian tissue: Therapeutic applications.
    Huh H; Wong S; St Jean J; Slavcev R
    Adv Drug Deliv Rev; 2019 May; 145():4-17. PubMed ID: 30659855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diverse Impacts of Phage Morons on Bacterial Fitness and Virulence.
    Taylor VL; Fitzpatrick AD; Islam Z; Maxwell KL
    Adv Virus Res; 2019; 103():1-31. PubMed ID: 30635074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages.
    Peng H; Borg RE; Dow LP; Pruitt BL; Chen IA
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1951-1961. PubMed ID: 31932441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages and cancer.
    Budynek P; Dabrowska K; Skaradziński G; Górski A
    Arch Microbiol; 2010 May; 192(5):315-20. PubMed ID: 20232198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophages of the Urinary Microbiome.
    Miller-Ensminger T; Garretto A; Brenner J; Thomas-White K; Zambom A; Wolfe AJ; Putonti C
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29378882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.